MAP PHARMACEUTICALS, INC.: filings

Name: MAP PHARMACEUTICALS, INC.: filings
Creator: MAP PHARMACEUTICALS, INC.
License: https://creativecommons.org/licenses/by/4.0/

Every MAP PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 8 filings, each linked to its SEC index.

Filing record ends 2012-11-06

The latest filing in this captured record is a 10-Q filed 2012-11-06. No later filing is in the SEC companyfacts record captured on 2026-09-23. MAP PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

Form	Filed	Fiscal period	Measures	Facts	SEC accession
10-Q	2012-11-06	fiscal Q3 2012	37	123	0001193125-12-453065
10-Q	2012-07-27	fiscal Q2 2012	33	104	0001193125-12-317553
10-Q	2012-05-08	fiscal Q1 2012	33	84	0001193125-12-218884
10-K	2012-03-30	fiscal FY 2011	34	118	0001193125-12-143583
10-Q/A	2012-03-30	fiscal Q3 2011	36	112	0001193125-12-143565
10-Q/A	2012-03-30	fiscal Q2 2011	32	95	0001193125-12-143550
10-Q	2011-11-08	fiscal Q3 2011	36	112	0001193125-11-302254
10-Q	2011-08-08	fiscal Q2 2011	36	111	0001193125-11-214428

Inspect the source

Entity: MAP PHARMACEUTICALS, INC. / CIK 0001401923
Captured: 2026-09-23 02:52 UTC
SEC response SHA-256: 3e606a38601942bec09d76b3c687236669d5a2a1d8f1ccd4309b23a73a20a456

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001401923.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))